Systematic review shows robotic colorectal surgery lowers CRP and complications versus laparoscopy in adult patientsRobotic surgery shows lower inflammation markers in colorectal cancer patients

A comprehensive systematic review and meta-analysis evaluated the impact of robotic surgery versus laparoscopic surgery on postoperative outcomes in adult patients following elective abdominal procedures. The study pooled data from 1706 participants, comprising 714 cases involving robotic assistance and 992 utilizing laparoscopic techniques. The primary focus was on measuring postoperative day 3 C-reactive protein (CRP) levels, a key biomarker for systemic inflammation and surgical stress. Secondary outcomes included complication rates, intraoperative blood loss, total operative duration, and length of hospital stay. The analysis aimed to determine if the higher cost and longer setup time of robotic platforms were justified by superior clinical outcomes.

The results indicated a statistically significant reduction in postoperative day 3 CRP levels for patients undergoing robotic surgery compared to those receiving laparoscopic care. The mean difference was -13.18 mg/l with a 95% confidence interval ranging from -22.29 to -4.08, and a p-value of 0.005. This finding was particularly robust within the colorectal cancer surgery subgroup, where the mean difference reached -17.22 mg/l. The confidence interval for this subgroup was -26.28 to -8.17, with a highly significant p-value of 0.0002 and an I-squared value of 0%, indicating no heterogeneity between studies in this specific category.

Beyond inflammatory markers, the study assessed safety and resource utilization. Complication rates were significantly lower with robotic surgery, achieving statistical significance with a p-value of 0.02. However, the absolute numbers for these complications were not reported in the source data. Regarding intraoperative blood loss, there was a non-significant trend toward reduced loss with the robotic approach, though this did not reach statistical significance with a p-value of 0.15. These findings suggest a potential advantage in minimizing tissue trauma, although the precise biological mechanisms remain to be fully elucidated.

Operative duration was notably longer with robotic surgery, with a mean difference of 24 minutes favoring the laparoscopic approach. The specific p-value and confidence intervals for this duration difference were not reported in the provided data. Conversely, the length of hospital stay showed a non-significant trend toward shorter durations for patients undergoing robotic procedures, with a p-value of 0.16. This suggests that while the initial procedure takes longer, the overall recovery trajectory might be accelerated, potentially offsetting the initial time investment.

The overall risk of bias in the included studies was assessed as moderate. No serious adverse events, discontinuations, or specific tolerability issues were reported in the safety section of the analysis. Funding sources and potential conflicts of interest were not reported for the primary studies included in this meta-analysis. The authors caution that while the findings support the hypothesis that robotic surgery minimizes tissue trauma, the exact biological mechanisms behind these observations are not yet fully understood.

The practice relevance of these findings suggests that the choice of surgical approach could be influenced by patient-specific factors, particularly for those with colorectal cancer. The significant reduction in inflammatory markers and complication rates may outweigh the increased operative time for selected candidates. Clinicians should weigh the moderate risk of bias and the lack of reported funding details when interpreting these results. Ultimately, this analysis provides evidence that robotic surgery offers distinct advantages in reducing postoperative inflammation and complications for colorectal cancer patients, despite the trade-off of a longer surgical duration.